CNBC Television·2026-07-27 17:34Market Trends & Energy Dynamics - Crude oil prices experienced a sharp pullback, with West Texas Intermediate (WTI) dropping close to 8% to trade at $82.35 per barrel following a pause in US strikes on Iran [1][5][16] - Brent crude snapped a 3-week rally after previously trading above 100 USD last week, while China scaled back oil imports by 4 million to 5 million barrels per day, acting as a major swing factor in market balancing [17][33][41] - The shipping traffic through the Bab el-Mandeb strait continued to face pressure and decline amid regional security risks [20][24] Investment & Technology Sector - Wall Street watcher Steve Eisman reduced exposure to artificial intelligence by trimming long-held stakes in Alphabet, warning that the market is overly concentrated on a single AI trade [2][9][61] - Nvidia engaged in discussions to provide a 250 billion USD financial backstop for OpenAI to support a 10 gigawatt data center project in southern Ohio developed by a SoftBank subsidiary [48] - Alphabet increased its capital expenditures from 190 billion to 205 billion USD, reflecting heightened capital intensity and spending concerns across major tech hyperscalers [54] Healthcare & Clinical Trials - Stanford neurologist Frank Longo and co-founder Anne Longo developed an oral pill drug (LM11A31 or compound 31) through Pharmatrophics targeting Alzheimer's disease by preserving synaptic connections [76][77][89] - Phase 2 clinical trials involving approximately 240 patients demonstrated that compound 31 significantly slowed brain degeneration and reversed network function loss compared to a placebo [81][83] - Over 7 million Americans are living with Alzheimer's disease, and Pharmatrophics scaled up drug production to prepare for upcoming phase 3 trials and broader rare disease applications [76][90][93][102]